|
|||||
|
|
Dipeptidyl peptidase-4 inhibitor,anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes |
|
| Authors: | Takahiro Abe Yasuhiro Matsubayashi Sayaka Muragishi Akihiro Yoshida Hideki Suganami Kenichi Furusawa Kazuya Fujihara Shiro Tanaka Kohei Kaku Hirohito Sone |
| Affiliation: | 1. Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan;2. Kowa Co., Ltd., Tokyo, Japan;3. Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan Kowa Co., Ltd., Tokyo, Japan;4. Sanwa Kagaku Kenkyusho Co., Ltd., Nagoya, Japan;5. Department of Clinical Biostatistics, Graduate School of Medicine Kyoto University, Kyoto, Japan;6. Kawasaki Medical School, Okayama, Japan |
| Abstract: | |
| Keywords: | Dipeptidyl peptidase-4 inhibitor Hepatic insulin clearance Meal tolerance test |